🇺🇸 FDA
Pipeline program

dactinomycin

CDR0000068608

Phase 3 mab active

Quick answer

dactinomycin for Sarcoma is a Phase 3 program (mab) at Solid Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Solid Biosciences
Indication
Sarcoma
Phase
Phase 3
Modality
mab
Status
active

Clinical trials